The AI engine Fit Assessment
BetaDelta 4 effectively utilizes machine learning for drug discovery, identifies new patterns in drug-disease relationships, and expands therapeutic options through drug repurposing.
Blurb
HQ Location
Founded
Employees
Total funding raised
Last Funding Event
Smart insights
Operator of a digital drug discovery and development company intended to drive the forefront of digital drug discovery and development. The company's platform leverages a proprietary computational analytics platform, combined with straightforward biomedical testing and clinical validation of candidate drugs, and integrates iterative big data with an artificial intelligence-based in-silico platform and experimental screens, enabling researchers to discover treatments for the most complex and rare diseases and offer them efficient matching of clinical indications and compound/drug effect.